×
Venus Concept Receivables 2016-2024 | VERO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Venus Concept receivables from 2016 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Venus Concept Receivables 2016-2024 | VERO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Venus Concept receivables from 2016 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$214.1B
Intuitive Surgical (ISRG)
$211.1B
Alcon (ALC)
$41.6B
Edwards Lifesciences (EW)
$41.2B
IQVIA Holdings (IQV)
$35.8B
IDEXX Laboratories (IDXX)
$34.3B
DexCom (DXCM)
$33B
Waters (WAT)
$24B
STERIS (STE)
$20.7B
SONOVA HOLDING (SONVY)
$19.7B
Hologic (HOLX)
$15.7B
Fresenius Medical Care AG KGaA (FMS)
$13.5B
Globus Medical (GMED)
$12.4B
Sysmex ADR (SSMXY)
$11.7B
Penumbra (PEN)
$10.1B
Masimo (MASI)
$9.2B
Glaukos (GKOS)
$8.6B
Teleflex (TFX)
$8.4B
Integer Holdings (ITGR)
$4.7B
Inari Medical (NARI)
$4.7B
PROCEPT BioRobotics (PRCT)
$4B
Veracyte (VCYT)
$3.1B
Nihon Kohden (NHNKY)
$2.7B
LivaNova (LIVN)
$2.6B
Tandem Diabetes Care (TNDM)
$2.3B
Elekta AB (EKTAY)
$2.2B
TransMedics (TMDX)
$1.9B
Integra LifeSciences Holdings (IART)
$1.9B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B